文献速递心境障碍儿童青少年精神

行为激活治疗围产期自杀意念:非劣效随机临床试验的二次分析

Behavioral Activation for Perinatal Suicide Ideation: Secondary Analysis of a Noninferiority Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2025-01-01

该研究为SUMMIT非劣效4臂随机临床试验的二次分析,纳入1230名围产期抑郁成人,其中1117名完成至少一次治疗并纳入分析。

要点

  • 简短行为激活治疗中,每增加一次治疗,自杀意念报告 odds 降低25%。
  • 随机化后3个月自杀意念报告 odds 较治疗期间降低80%。
  • 自杀意念变化不因临床医生类型(非专家 vs 专家)或递送方式(远程 vs 面对面)而异。

核心结论

  • 在围产期抑郁的简短行为激活治疗过程中,报告自杀意念的可能性下降,随机化后3个月下降最显著,且不受临床医生或递送方式影响。
  • 行为激活可能是围产期自杀预防的一种循证、可扩展的方法。

研究设计与样本

  • SUMMIT多站点、非劣效、4臂随机临床试验的二次分析,比较临床医生类型(非专家 vs 专家)和递送方式(远程医疗 vs 面对面)的行为激活。
  • 参与者为2020年1月至2023年10月从芝加哥、教堂山和多伦多大学附属网络招募的妊娠≤36周或产后4-30周、EPDS评分≥10的成人。
  • 干预为手册化每周1次、共6-8次的行为激活治疗;主要结局为EPDS第10项测量的自杀意念,每周及随机化后3个月评估。

主要发现

  • 共1230名围产期成人入组,1117名完成至少一次治疗并纳入分析;其中264名(23.6%)在治疗期间报告自杀意念,平均年龄33.4(SD 4.9)岁。
  • 自杀意念报告 odds 在临床医生类型(非专家 vs 专家)或递送方式(远程医疗 vs 面对面)之间无差异。
  • 拟合优度χ2检验表明,参与者在治疗开始时报告C-SSRS自杀想法的可能性显著高于其他任何时间点。

关键数值与推荐

  • EPDS评分≥10定义围产期抑郁症状;EPDS第10项用于评估自杀意念,阳性者随后用C-SSRS进一步安全评估。

临床怎么用

  • 对于围产期抑郁且EPDS≥10的成人,简短行为激活治疗可能作为减少自杀意念的可扩展干预。
  • 治疗过程中应每周评估自杀意念,并在治疗结束后3个月继续关注。
  • 行为激活可由非专家或专家通过远程医疗或面对面递送,对自杀意念的影响无差异。

局限性

  • 本文为二次分析,主要结局非原始试验主要终点。
  • 自杀意念通过EPDS第10项自报评估,可能存在报告偏倚。
  • 未报告盲法、脱落率及长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Suicide is a leading cause of maternal postpartum death. Evidence-based interventions are needed. OBJECTIVE: To determine whether the likelihood of endorsing suicide ideation (SI) changed during a brief behavioral activation (BA) psychotherapy for perinatal depression irrespective of clinician or delivery types. DESIGN, SETTING, AND PARTICIPANTS: This is a secondary analysis of a multisite, noninferiority, 4-arm randomized clinical trial called SUMMIT(Scaling Up Maternal Mental Health Care by Increasing Access to Treatment). SUMMIT compared clinicians (nonspecialist vs specialist) and modalities (telemedicine vs in person) in delivering BA. Participants were enrolled from January 2020 to October 2023. The study was conducted at university-affiliated networks in Chicago, Illinois; Chapel Hill, North Carolina; and Toronto, Canada. Pregnant (≤36 weeks) and postpartum (4-30 weeks) adults with depressive symptoms (Edinburgh Postnatal Depression Scale [EPDS] score ≥10) were enrolled. Secondary data analyses were conducted in November 2024. INTERVENTION: A manualized 6- to 8-session perinatal BA intervention delivered weekly. MAIN OUTCOMES AND MEASURES: The primary outcome was SI, as measured by the EPDS item 10, assessed weekly and at 3 months postrandomization. SI endorsements were followed by the Columbia Suicide Severity Rating Scale (C-SSRS) for further safety assessment. RESULTS: A total of 1230 pregnant and postpartum adults were enrolled, among whom 1117 completed 1 or more treatment session and provided 1 or more week of EPDS data and thus were included in the current study. Of 1117 included participants, 264 (23.6%) endorsed SI during treatment, and mean (SD) age was 33.4 (4.9) years. Cumulative link mixed models indicated that the odds of endorsing SI decreased by 25% with each additional treatment session (odds ratio [OR], 0.75; 95% CI, 0.58-0.96; P = .03). The odds of endorsing SI decreased by 80% at 3 months postrandomization compared with any time during treatment (OR, 0.20; 95% CI, 0.14-0.27; P < .001). The odds of endorsing SI did not differ between clinician type (nonspecialist vs specialist) or modality (telemedicine vs in person). Goodness-of-fit χ2 tests further indicated that participants were significantly more likely to endorse suicide thoughts on the C-SSRS at treatment onset compared with any other time point. CONCLUSIONS AND RELEVANCE: In this secondary analysis of the SUMMIT noninferiority randomized clinical trial, the likelihood of endorsing SI decreased over the course of a brief BA psychotherapy for perinatal depression and most significantly at 3 months postrandomization, irrespective of clinician or delivery types. BA may be one evidence-based, scalable approach for perinatal suicide prevention. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04153864.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kaliush PR, Molina NC, Berenbaum TS, et al. Behavioral Activation for Perinatal Suicide Ideation: Secondary Analysis of a Noninferiority Randomized Clinical Trial. JAMA Psychiatry. 2025. PMID: 40833774. doi:10.1001/jamapsychiatry.2025.2116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。